Document is current
Any future updates will be listed below
-
Authors
Ward, Laura
Faria, Claudia C.
Mota, Maria M. https://orcid.org/0000-0002-2858-1041
de Magalhães, João Pedro https://orcid.org/0000-0002-6363-2465
Kennedy, Brian K. https://orcid.org/0000-0002-5754-1874
Ferreira, Miguel Godinho https://orcid.org/0000-0002-8363-7183
Neves, Joana https://orcid.org/0000-0002-1027-3489
Sousa-Victor, Pedro https://orcid.org/0000-0002-6521-7839
-
Funding
Funding for this research was provided by:
European Commission (101060102)
European Commission (101060102)
European Commission (101060102)
European Commission (101060102)
European Commission (101060102)
- License Information
-
More Information
Article History
First Online: 28 May 2026
Competing interests
: J.P.d.M. is chief scientific officer of YouthBio Therapeutics, an advisor/consultant for the BOLD Longevity Growth Fund and NOVOS, and the founder of Magellan Science Ltd, a company providing consulting services in longevity science. B.K.K. is supported by a Healthy Longevity Catalyst grant (HLCA25Jan-0012) and is a scientific advisor and board member of PDL Health, which produces Rejuvant. All other authors declare no competing interests.
